Kinase-inhibitors for iodine-refractory differentiated thyroid cancer: Still far from a structured therapeutic algorithm
V Marotta, MG Chiofalo, F Di Gennaro… - Critical Reviews in …, 2021 - Elsevier
The kinase-inhibitors (KIs) sorafenib and lenvatinib demonstrated efficacy in iodine-
refractory DTC upon phase III studies. However, evidence allowing a punctual balance of …
refractory DTC upon phase III studies. However, evidence allowing a punctual balance of …
Tumor Microenvironment–Associated Pericyte Populations May Impact Therapeutic Response in Thyroid Cancer
A Iesato, C Nucera - Tumor Microenvironment: Novel Concepts, 2021 - Springer
Thyroid cancer is the most common endocrine malignancy, and aggressive radioactive
iodine refractory thyroid carcinomas still lack an effective treatment. A deeper understanding …
iodine refractory thyroid carcinomas still lack an effective treatment. A deeper understanding …
BRAF V600E Immunoexpression in Papillary Thyroid Carcinoma and Its Association with Prognostic Factors and Histopathologic Variant
Aim: to provide additional information regarding the clinicopathological characteristics of
Papillary Thyroid Carcinoma (PTC). Methods: Fifty patient with PTC were reviewed to …
Papillary Thyroid Carcinoma (PTC). Methods: Fifty patient with PTC were reviewed to …
[HTML][HTML] Факторы риска онкогенеза щитовидной железы. Вклад генетических мутаций, онкогенов, дисэлементозов и ростовых факторов в формирование …
ЛВ Квиткова, АС Халимова - Эндокринология: Новости. Мнения …, 2021 - cyberleninka.ru
Проблема роста доброкачественных и злокачественных опухолей щитовидной
железы (ЩЖ) в последние годы встает особенно остро. В структуре всех …
железы (ЩЖ) в последние годы встает особенно остро. В структуре всех …
Therapeutic Vascular and Immune Normalization in the Melanoma Microenvironment Using STING Agonists
M Chelvanambi - 2021 - search.proquest.com
CD8+ T-cells are indispensable for immune-mediated rejection of solid cancers. Hence, the
conditional enhancement of intratumoral T-cell content and/or function defines a preferred …
conditional enhancement of intratumoral T-cell content and/or function defines a preferred …